Showing results (201-210 of 211) with videos related to

Sort By:
Pageof 22
Dementia and Geriatric Cognitive Disorders|February 18, 2006
Clinical determinants of dementia and mild cognitive impairment following ischaemic stroke: the Sydney Stroke StudyP S Sachdev, H Brodaty, M J Valenzuela, et al.
World Journal of Surgery|March 10, 2017
Survey of Emergency and Essential Surgical, Obstetric and Anaesthetic Services Available in Bangladeshi Government Health FacilitiesJonathan Loveday, Sonal P Sachdev, Meena N Cherian, et al.
Psychological Medicine|February 24, 2005
Memory complaints in a community sample aged 60-64 years: associations with cognitive functioning, psychiatric symptoms, medical conditions, APOE genotype, hippocampus and amygdala volumes, and white-matter hyperintensitiesA F Jorm, P Butterworth, K J Anstey, et al.
Surgical Neurology|February 1, 1983
Bilateral intracavernous carotid aneurysms mimicking a prolactin-secreting pituitary tumorJ S Mindel, V P Sachdev, L B Kline, et al.
Neuroimage. Clinical|July 24, 2018
Differentiation of Alzheimer's disease based on local and global parameters in personalized Virtual Brain modelsJ Zimmermann, A Perry, M Breakspear, et al.
Bioscience, Biotechnology, and Biochemistry|May 2, 2001
Unique occurrence of the 1CF11 carbohydrate epitope in primate salivaS M Yang, N Yokoi, Y Kanamaru, et al.
The Journal of Prevention of Alzheimer'S Disease|February 4, 2020
Associations of Later-Life Education, the BDNF Val66Met Polymorphism and Cognitive Change in Older AdultsD D Ward, M J Summers, M J Valenzuela, et al.
American Journal of Respiratory Cell and Molecular Biology|March 1, 1997
Chromosomal localization of a human mucin gene (MUC8) and cloning of the cDNA corresponding to the carboxy terminusV Shankar, P Pichan, R L Eddy, et al.
Brain Imaging and Behavior|November 17, 2016
Midlife managerial experience is linked to late life hippocampal morphology and functionC Suo, N Gates, M Fiatarone Singh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2024
Biomarker analyses from the phase III randomized CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinomaR J Motzer, C Porta, M Eto, et al.
Pageof 22